Olivia Cano‐Garrido

1.2k total citations
38 papers, 963 citations indexed

About

Olivia Cano‐Garrido is a scholar working on Molecular Biology, Ecology and Biotechnology. According to data from OpenAlex, Olivia Cano‐Garrido has authored 38 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Ecology and 13 papers in Biotechnology. Recurrent topics in Olivia Cano‐Garrido's work include Bacteriophages and microbial interactions (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Cancer Research and Treatments (9 papers). Olivia Cano‐Garrido is often cited by papers focused on Bacteriophages and microbial interactions (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Cancer Research and Treatments (9 papers). Olivia Cano‐Garrido collaborates with scholars based in Spain, Argentina and United States. Olivia Cano‐Garrido's co-authors include Elena García‐Fruitós, Antonio Villaverde, Joaquin Seras‐Franzoso, Esther Vázquez, Alejandro Sánchez‐Chardi, Ugutz Unzueta, Naroa Serna, Laura Sánchez‐García, Ramón Mangues and Escarlata Rodríguez‐Carmona and has published in prestigious journals such as Advanced Materials, Biomaterials and Advanced Functional Materials.

In The Last Decade

Olivia Cano‐Garrido

38 papers receiving 957 citations

Peers

Countries citing papers authored by Olivia Cano‐Garrido

Since Specialization

Citations

This map shows the geographic impact of Olivia Cano‐Garrido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Cano‐Garrido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Cano‐Garrido more than expected).

Fields of papers citing papers by Olivia Cano‐Garrido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Cano‐Garrido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Cano‐Garrido. The network helps show where Olivia Cano‐Garrido may publish in the future.

Co-authorship network of co-authors of Olivia Cano‐Garrido

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Cano‐Garrido. A scholar is included among the top collaborators of Olivia Cano‐Garrido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Cano‐Garrido. Olivia Cano‐Garrido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protein scaffolds in human clinics 2022 ·Biotechnology Advances ·Olivia Cano‐Garrido, Naroa Serna, Ugutz Unzueta, Eloi Parladé, Ramón Mangues, Antonio Villaverde, Esther Vázquez	13
2	Purification of Inclusion Bodies Produced in Bacteria and Yeast 2022 ·Methods in molecular biology ·Joaquin Seras‐Franzoso, Olivia Cano‐Garrido, Špela Peternel, Anna Arı́s, Elena García‐Fruitós	1
3	Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells 2022 ·Frontiers in Bioengineering and Biotechnology ·Irene Barguilla, Ugutz Unzueta, (unknown), Olivia Cano‐Garrido, Antonio Villaverde, Alba Hernández, Neus Ferrer‐Miralles	2
4	The Potential of Metalloproteinase-9 Administration to Accelerate Mammary Involution and Boost the Immune System at Dry-Off 2021 ·Animals ·(unknown), Olivia Cano‐Garrido, À. Bach, Neus Ferrer‐Miralles, Antonio Villaverde, Elena García‐Fruitós, Anna Arı́s	3
5	Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format 2020 ·Pharmaceutics ·(unknown), Estefanía Ugarte-Berzal, Erik Martens, (unknown), Olivia Cano‐Garrido, (unknown), Teresa Luque, (unknown), Oscar Conchillo‐Solé, Neus Ferrer‐Miralles, Antonio Villaverde, Ghislain Opdenakker, Elena García‐Fruitós, Anna Arı́s	7
6	The Biological Potential Hidden in Inclusion Bodies 2020 ·Pharmaceutics ·(unknown), Joaquin Seras‐Franzoso, Diana Rafael, Fernanda Andrade, Olivia Cano‐Garrido, (unknown), Estefanía Ugarte-Berzal, Erik Martens, (unknown), Antonio Villaverde, Ghislain Opdenakker, Simó Schwartz, Anna Arı́s, Elena García‐Fruitós	19
7	Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles 2020 ·Acta Biomaterialia ·Eric Voltà‐Durán, Naroa Serna, Laura Sánchez‐García, Anna Aviñó, Julieta M. Sánchez, Hèctor López‐Laguna, Olivia Cano‐Garrido, Isolda Casanova, Ramón Mangues, Ramón Eritja, Esther Vázquez, Antonio Villaverde, Ugutz Unzueta	16
8	Release of functional fibroblast growth factor-2 from artificial inclusion bodies 2020 ·Journal of Controlled Release ·Naroa Serna, Olivia Cano‐Garrido, Julieta M. Sánchez, Alejandro Sánchez‐Chardi, Laura Sánchez‐García, Hèctor López‐Laguna, E. Fernández, Esther Vázquez, Antonio Villaverde	22
9	Aggregation-prone peptides modulate activity of bovine interferon gamma released from naturally occurring protein nanoparticles 2020 ·New Biotechnology ·(unknown), Olivia Cano‐Garrido, Julieta M. Sánchez, (unknown), (unknown), Oscar Conchillo‐Solé, Xavier Daura, Alejandro Sánchez‐Chardi, Antonio Villaverde, Anna Arı́s, Elena García‐Fruitós, Neus Ferrer‐Miralles	10
10	Artificial Inclusion Bodies for Clinical Development 2019 ·Advanced Science ·Julieta M. Sánchez, Hèctor López‐Laguna, Patricia Álamo, Naroa Serna, Alejandro Sánchez‐Chardi, (unknown), Olivia Cano‐Garrido, Isolda Casanova, Ugutz Unzueta, Esther Vázquez, Ramón Mangues, Antonio Villaverde	47
11	Assembly of histidine-rich protein materials controlled through divalent cations 2018 ·Acta Biomaterialia ·Hèctor López‐Laguna, Ugutz Unzueta, Oscar Conchillo‐Solé, Alejandro Sánchez‐Chardi, Mireia Pesarrodona, Olivia Cano‐Garrido, Eric Voltà‐Durán, Laura Sánchez‐García, Naroa Serna, Paolo Saccardo, Ramón Mangues, Antonio Villaverde, Esther Vázquez	55
12	Protein Nanoparticles are nontoxic, Tuneable Cell Stressors 2018 ·Nanomedicine ·Marianna Teixeira de Pinho Favaro, Laura Sánchez‐García, Alejandro Sánchez‐Chardi, Mónica Roldán, Ugutz Unzueta, Naroa Serna, Olivia Cano‐Garrido, Adriano Rodrigues Azzoni, Neus Ferrer‐Miralles, Antonio Villaverde, Esther Vázquez	10
13	Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach 2018 ·Journal of Controlled Release ·Ugutz Unzueta, María Virtudes Céspedes, Rita Sala, Patricia Álamo, Alejandro Sánchez‐Chardi, Mireia Pesarrodona, Laura Sánchez‐García, Olivia Cano‐Garrido, Antonio Villaverde, Esther Vázquez, Ramón Mangues, Joaquin Seras‐Franzoso	29
14	Functional protein-based nanomaterial produced in microorganisms recognized as safe: A new platform for biotechnology 2016 ·Acta Biomaterialia ·Olivia Cano‐Garrido, Alejandro Sánchez‐Chardi, (unknown), (unknown), (unknown), Neus Ferrer‐Miralles, Imma Ratera, Antonino Natalello, Rafael Cubarsí, Jaume Veciana, À. Bach, Antonio Villaverde, Anna Arı́s, Elena García‐Fruitós	42
15	Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes 2015 ·Microbial Cell Factories ·Olivia Cano‐Garrido, Joaquin Seras‐Franzoso, Elena García‐Fruitós	123
16	Expanding the recombinant protein quality in Lactococcus lactis 2014 ·Microbial Cell Factories ·Olivia Cano‐Garrido, (unknown), Laura Sánchez‐García, Luis Ruíz-Ávila, (unknown), Antonio Villaverde, Elena García‐Fruitós	27
17	Production of functional inclusion bodies in endotoxin-free Escherichia coli 2014 ·Applied Microbiology and Biotechnology ·(unknown), Olivia Cano‐Garrido, Uwe Mamat, Kathleen Wilke, Joaquin Seras‐Franzoso, Elena García‐Fruitós, Antonio Villaverde	40
18	Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies 2012 ·Acta Biomaterialia ·Olivia Cano‐Garrido, Escarlata Rodríguez‐Carmona, César Díez‐Gil, Esther Vázquez, Elisa Elizondo, Rafael Cubarsí, Joaquin Seras‐Franzoso, José Luís Corchero, Ursula Rinas, Imma Ratera, Nora Ventosa, Jaume Veciana, Antonio Villaverde, Elena García‐Fruitós	58
19	Co-production of GroELS discriminates between intrinsic and thermally-induced recombinant protein aggregation during substrate quality control 2011 ·Microbial Cell Factories ·(unknown), Escarlata Rodríguez‐Carmona, Elena García‐Fruitós, Olivia Cano‐Garrido, Antonio Villaverde	9
20	The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation 2010 ·Biomaterials ·César Díez‐Gil, Sven O. Krabbenborg, Elena García‐Fruitós, Esther Vázquez, Escarlata Rodríguez‐Carmona, Imma Ratera, Nora Ventosa, Joaquin Seras‐Franzoso, Olivia Cano‐Garrido, Neus Ferrer‐Miralles, Antonio Villaverde, Jaume Veciana	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact